Pillstats
Rx only · Tablet · Oral

Griseofulvin

Brands: Ultramicrosize Griseofulvin · Griseofulvin

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US9 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCD01AA08
RxCUI (US)5021
US makers4 labelers
Packages14
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 11 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.39$2.78$4.18$5.57Jul 2025Mar 2026Jul 2026
$4.437
Latest avg · Jul 22, 2026
+33%
Since Jul 23, 2025
4
Active US suppliers
71%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.1K4.3K6.4K8.6K2025 Q12025 Q22025 Q32025 Q42026 Q1
5.1K
Rx · 2026 Q1
213K
Units dispensed
-29%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it4 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Chartwell RX, LLCunknown6SUPPLYING
Sandoz Incunknown4SUPPLYING
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.unknown3SUPPLYING
SIGMAPHARM LABORATORIES, LLCunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.